M
50
-3
GLW
41
-4
GE
58
-2
CCL
72
2
RF
48
-3
HRL
50
-3
MOS
50
4
CVS
36
-8
MCO
78
3
LEG
36
5
AMGN
33
-3
PBI
66
3
MCK
52
-3
PNW
59
-4
DGX
29
-3
AVB
57
2
ABBV
40
-2
STZ
55
-3
PNR
72
3
ISRG
71
3
M
50
-3
GLW
41
-4
GE
58
-2
CCL
72
2
RF
48
-3
HRL
50
-3
MOS
50
4
CVS
36
-8
MCO
78
3
LEG
36
5
AMGN
33
-3
PBI
66
3
MCK
52
-3
PNW
59
-4
DGX
29
-3
AVB
57
2
ABBV
40
-2
STZ
55
-3
PNR
72
3
ISRG
71
3
Financhill
Back

Ligand Pharmaceuticals Quote, Financials, Valuation and Earnings

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Buy
51

LGND
Ligand Pharmaceuticals

Last Price:
113.46
Seasonality Move:
11.95%

7 Day Trial

ALL ACCESS PASS

$ 7

Better Than Oil Stocks

CLICK HERE TO FIND OUT MORE

Ligand Pharmaceuticals Price Quote

$113.46
-0.05 (-5.73%)
(Updated: December 13, 2024 at 3:31 AM ET)

Ligand Pharmaceuticals Key Stats

Buy
51
Ligand Pharmaceuticals (LGND) is a Buy
Day range:
$113.39 - $120.94
52-week range:
$65.84 - $129.90
Dividend yield:
0%
P/E ratio:
38.61
P/S ratio:
13.45
P/B ratio:
2.55%
Volume:
106.5K
Avg. volume:
131.4K
1-year change:
80.35%
Market cap:
$2.1B
Revenue:
$131.3M
EPS:
$2.51

How Much Does Ligand Pharmaceuticals Make?

Is Ligand Pharmaceuticals Growing As A Company?

Ligand Pharmaceuticals Stock Price Performance

What Is Ligand Pharmaceuticals 52-Week High & Low?

Ligand Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Ligand Pharmaceuticals?

Is Ligand Pharmaceuticals Cash Flow Positive?

  • What Is LGND Cash Flow From Operations?
    Cash flow from operations (TTM) is $76.6M
  • What Is Ligand Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $82.1M
  • What Is Ligand Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$115.3M

Ligand Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    LGND return on invested capital is 5.97%
  • What Is Ligand Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 5.27%
  • What Is LGND Return On Equity?
    ROE is a measure of profitability and is 5.97%

Ligand Pharmaceuticals Earnings Date & Stock Price

Ligand Pharmaceuticals Competitors

Ligand Pharmaceuticals Dividend Yield

Ligand Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 36.66%
Revenue: 57.64% 27.61%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 141.13
Upside from Last Price: 24.33%

Major Shareholders

  • How many LGND shares are owned by institutional investors?
    30.8M LGND shares are owned by institutional investors
  • How many LGND shares are owned by insiders?
    2M LGND shares are owned by insiders